These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 30804354)
1. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study. Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354 [TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer. Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070 [TBL] [Abstract][Full Text] [Related]
3. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer. Peng W; Zhou Z; Zhong Y; Sun Y; Wang Y; Zhu Z; Jiao W; Bai M; Sun J; Lu J; Yin H Sci Rep; 2019 Dec; 9(1):19084. PubMed ID: 31836775 [TBL] [Abstract][Full Text] [Related]
4. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer. Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357 [TBL] [Abstract][Full Text] [Related]
5. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790 [TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China. Ma L; Xie XW; Wang HY; Ma LY; Wen ZG Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610 [TBL] [Abstract][Full Text] [Related]
7. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer. Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270 [TBL] [Abstract][Full Text] [Related]
8. Prediction of lung cancer based on serum biomarkers by gene expression programming methods. Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226 [TBL] [Abstract][Full Text] [Related]
9. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432 [TBL] [Abstract][Full Text] [Related]
10. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients. Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537 [TBL] [Abstract][Full Text] [Related]
11. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701 [TBL] [Abstract][Full Text] [Related]
12. Blood test shows high accuracy in detecting stage I non-small cell lung cancer. Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275 [TBL] [Abstract][Full Text] [Related]
14. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
15. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial. Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. Su K; Zhang T; Wang Y; Hao G World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients. Fan J; Yu H; Lv Y; Yin L Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622 [TBL] [Abstract][Full Text] [Related]
19. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer. Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318 [TBL] [Abstract][Full Text] [Related]
20. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]